{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:47:14Z","timestamp":1788191234950,"version":"build-2803163510"},"reference-count":35,"publisher":"Universa BV","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Orthop Belg"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>Metastasis stands as one of the most prominent prognostic factors in osteosarcoma. Over 70% of metastatic osteosarcoma occurrences affect the lung. Nonetheless, to date, there has been a scarcity of research addressing predictive factors for lung metastasis risk in osteosarcoma. The objective of this study is to identify the predictive factors that have a role in the risk of lung metastasis in osteosarcoma. This is a retrospective study conducted between January 2018 until January 2023. From the obtained research subjects, an assessment selection was carried out using inclusion and exclusion criteria. Subsequently, preoperative data related to predictive factors will be collected from the research subjects, followed by a clinicopathological conference, chemotherapy, and surgery. Afterward, an evaluation of pulmonary metastasis will be conducted six months after the diagnosis. A total of 47 osteosarcoma patients who met the inclusion and exclusion criteria were analyzed. Bivariate and multivariate logistic regression analyses revealed statistically significant predictive factors for the risk of pulmonary metastasis in osteosarcoma: ALP levels (p=0.014), LDH levels (p=0.038), presence of pathological fractures (p=0.025), and tumor size (p=0.027).<\/jats:p>","DOI":"10.52628\/90.4.12808","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:37:17Z","timestamp":1737977837000},"page":"739-743","source":"Crossref","is-referenced-by-count":2,"title":["Predictive Factors for Lung Metastasis in High-Grade Osteosarcoma: A 5 Years Experience from Tertiary Referral Hospital"],"prefix":"10.52628","volume":"90","author":[{"given":"Y.A.","family":"PRABOWO PUTRO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"MAGETSARI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"OKSIKIMBAWAN TAMPUBOLON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"FAIZ HUWAIDI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"ROSFADILLA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27062","published-online":{"date-parts":[[2025,1]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, et al. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American osteosarcoma study) cohort. Eur J Cancer. 2019;109:36\u201350.","DOI":"10.1016\/j.ejca.2018.11.027"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Song K, Song J, Chen F, Lin K, Ma X, Jiang J. Prognostic nomograms for predicting overall and cancer-specific survival of high-grade osteosarcoma patients. J Bone Oncol. 2018;13:106\u201313.","DOI":"10.1016\/j.jbo.2018.09.012"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Gorlick R, Janeway K, Lessnick S, Randall RL, Marina N. Children\u2019s oncology Group\u2019s 2013 blueprint for research: bone tumors. Pediatr Blood Cancer. 2013; 60:1009\u201315.","DOI":"10.1002\/pbc.24429"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Ikuta K, Kawamoto T, Hara H, Fukase N, Morishita M, Kuroda R, et al. Solitary pancreatic lesion as the initial metastasis from osteosarcoma: report of a rare case. J Orthop Sci. 2020;25:724\u20138.","DOI":"10.1016\/j.jos.2017.09.020"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Fujiwara T, Oda M, Yoshida A, et al. Atypical manifestation of lung metastasis 17 years after initial diagnosis of low-grade central osteosarcoma. J Orthop Sci. 2017;22:357\u201361.","DOI":"10.1016\/j.jos.2015.08.002"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Kaste SC, Pratt CB, Cain AM, Jones-Wallace DJ, Rao BN. Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: imaging features. Cancer. 1999;86:1602\u20138.Picci, P. (2007). Osteosarcoma (osteogenic sarcoma). Orphanet journal of rare diseases, 2, 1-4.","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1602::AID-CNCR31>3.0.CO;2-R"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Estrada-Villaseor E, Escamilla-Uribe R, De la Garza-Montano P, Dominguez- Rubio R, Martinez-Lopez V, Avila-Luna A, et al. Association of metastasis with clinicopathological data in Mexican patients with osteosarcoma, Giant cell tumor of bone and chondrosarcoma. Asian Pac J Cancer Prev. 2015;16:7689\u2013 94.","DOI":"10.7314\/apjcp.2015.16.17.7689"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Salah S, Toubasi S. Factors predicting survival following complete surgical remission of pulmonary metastasis in osteosarcoma. Mol Clin Oncol. 2015;3:157\u201362.","DOI":"10.3892\/mco.2014.426"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Zhang C, Guo X, Xu Y, Han X, Cai J, Wang X, et al. Lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study. Sao Paulo Med J. 2019;137:423\u20139.","DOI":"10.1590\/1516-3180.2018.0381120619"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Kusma J, Young C, Yin H, Stanek JR, Yeager N, Aldrink JH. Pulmonary nodule size <5 mm still warrants investigation in patients with osteosarcoma and Ewing sarcoma. J Pediatr Hematol Oncol. 2017;39:184\u20137","DOI":"10.1097\/mph.0000000000000753"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Federman N, Bernthal N, Eilber FC, et al. The multidisciplinary management of osteosarcoma. Curr Treat Options Oncol 2009; 10: 82-93.","DOI":"10.1007\/s11864-009-0087-3"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Matthew T , Martin L. Management of Osteosarcoma Pulmonary Metastases. Seminars in Pediatric Surgery . 2006. 15 ; p 25-29","DOI":"10.1053\/j.sempedsurg.2005.11.005"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Duffaud F, Digue L, Mercier C, Dales JP, Baciuchka-Palmaro M, Volot F, et al. Recurrences following primary osteosarcoma in adolescents and adults previously treated with chemotherapy. Eur J Cancer (Oxford Engl 1990) (2003) 39(14):2050\u20137.","DOI":"10.1016\/s0959-8049(03)00435-0"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Strauss SJ, McTiernan A, Whelan JS. Late relapse of osteosarcoma: implications for follow-up and screening. Pediatr Blood Cancer (2004) 43(6):692\u20137.","DOI":"10.1002\/pbc.20154"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Ferrari S, Briccoli A, Mercuri M, Bertoni F, Cesari M, Longhi A, et al. Late relapse in osteosarcoma. J Pediatr Hematol\/ Oncol (2006) 28(7):418\u201322.","DOI":"10.1097\/01.mph.0000212944.82361.1d"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Salah, Samer, and Samar Toubasi. \u201cFactors predicting survival following complete surgical remission of pulmonary metastasis in osteosarcoma.\u201d Molecular and clinical oncology 3.1 (2015): 157-162.","DOI":"10.3892\/mco.2014.426"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Song K, Song J, Lin K, Chen F, Ma X, Jiang J, et al. Survival analysis of patients with metastatic osteosarcoma: a surveillance, epidemiology, and end results population-based study. Int Orthop (2019) 43(8):1983\u201391.","DOI":"10.1007\/s00264-019-04348-4"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Kim SH, Shin KH, Moon SH, et al. Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma. Cancer Medicine. 2017;6(6):1311\u20131322.","DOI":"10.1002\/cam4.1022"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Hao H, Chen L, Huang D, et al. Meta-analysis of alkaline phosphatase and prognosis for osteosarcoma. European Journal of Cancer Care 2017;26, e12536(5).","DOI":"10.1111\/ecc.12536"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Ren, H. Y., L. L. Sun, H. Y. Li, and Z. M. Ye. 2015. Prognostic significance of serum alkaline phosphatase level in osteosarcoma: a meta-analysis of published data. BioMed Res. Int. 2015:160835.","DOI":"10.1155\/2015\/160835"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Vasquez, Liliana, et al. \u201cAnalysis of prognostic factors in high- grade osteosarcoma of the extremities in children: a 15-year single-institution experience.\u201d Frontiers in oncology 6 (2016): 22.","DOI":"10.3389\/fonc.2016.00022"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer (2006) 106:1154\u201361. doi:10.1002\/cncr.21724","DOI":"10.1002\/cncr.21724"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Bacci G, Longhi A, Ferrari S, Briccoli A, Donati D, De Paolis M, et al. Prognostic significance of serum lactate dehydrogenase in osteosarcoma of the extremity: experience at Rizzoli on 1421 patients treated over the last 30 years. Tumori (2004) 90:478\u201384.","DOI":"10.1177\/030089160409000507"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Zuo D, Zheng L, Sun W, Hua Y, Cai Z. Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case- control study. World J Surg Oncol 2013;11:148.","DOI":"10.1186\/1477-7819-11-148"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Bacci G, Ferrari S, Longhi A, et al. Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy. Acta Orthop Scand 2003;74:449\u2013454.","DOI":"10.1080\/00016470310017776"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Bramer JA, Abudu AA, Grimer RJ, Carter SR, Tillman RM. Do pathological fractures influence survival and local recurrence rate in bony sarcomas? Eur J Cancer 2007;43:1944\u20131951.","DOI":"10.1016\/j.ejca.2007.07.004"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Ferguson PC, McLaughlin CE, Griffin AM, et al. Clinical and functional outcomes of patients with a pathologic fracture in high-grade osteosarcoma. J Surg Oncol 2010;102:120\u2013124.","DOI":"10.1002\/jso.21542"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Chandrasekar CR, Grimer RJ, Carter SR, et al. Pathological fracture of the proximal femur in osteosarcoma: need for early radical surgery? ISRN Oncol 2012;2012:512389.","DOI":"10.5402\/2012\/512389"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Zhou Y, Lu Q, Xu J, Yan R, Zhu J, Xu J, Jiang X, Li J, Wu F. The effect of pathological fractures on the prognosis of patients with osteosarcoma: a meta-analysis of 14 studies. Oncotarget. 2017 Aug 21;8(42):73037-73049.","DOI":"10.18632\/oncotarget.20375"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Bieling P, Rehan N, Winkler P, Helmke K, Maas R, Fuchs N, et al. Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol 1996;14:848\u201358.","DOI":"10.1200\/jco.1996.14.3.848"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Shin KH, Moon SH, Suh JS, Yang WI. Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma. Clin Orthop Relat Res 2000;376:200\u20138.","DOI":"10.1097\/00003086-200007000-00027"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Holscher HC, Bloem JL, Nooy MA, Taminiau AH, Eulderink F, Hermans J. The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas. AJR Am J Roentgenol 1990;154:763\u20139.","DOI":"10.2214\/ajr.154.4.2107673"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Hudson M, Jaffe MR, Jaffe N, Ayala A, Raymond AK, Carrasco H, et al. Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience. J Clin Oncol 1990;8:1988\u201397.","DOI":"10.1200\/jco.1990.8.12.1988"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Munajat I, Zulmi W, Norazman MZ, Wan Faisham WI. Tumour volume and lung metastasis in patients with osteosarcoma. J Orthop Surg (Hong Kong). 2008 Aug;16(2):182-5.","DOI":"10.1177\/230949900801600211"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Xu G, Wu H, Zhang Y, et al. Risk and Prognostic Factors for Different Organ Metastasis in Primary Osteosarcoma: A Large Population-Based Analysis. Orthop Surg. 2022;14(4):714-719. doi:10.1111\/os.13243","DOI":"10.1111\/os.13243"}],"container-title":["Acta Orthopaedica Belgica"],"original-title":[],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:37:23Z","timestamp":1737977843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.actaorthopaedica.be\/archive\/volume-90\/issue-4\/original-studies\/predictive-factors-for-lung-metastasis-in-high-grade-osteosarcoma-a-5-years-experience-from-tertiary\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,1]]},"published-print":{"date-parts":[[2024,12]]}},"URL":"https:\/\/doi.org\/10.52628\/90.4.12808","relation":{},"ISSN":["0001-6462"],"issn-type":[{"value":"0001-6462","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}